Schedule 13G ownership disclosure
BELLICUM PHARMACEUTICALS INC
Security class unavailable · CUSIP: 079481107
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,583,840
- Percent of class
- 5.1800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-20-000087
- Form type
- SC 13G
- Filer
- BELLICUM PHARMACEUTICALS, INC
- CIK
- CIK 1358403
- Filed
- Feb 12, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership